Al Janaby, T. et al. 2025. Co-expression of HER2/EGFRvIII/CD44 and Claudin 18.2/CD109 as Novel Prognostic Indicators in Stomach Adenocarcinoma. World Journal of Oncology. 16, 3 (Jun. 2025), 254–268. DOI:https://doi.org/10.14740/wjon2552.